Skip to main content

Table 2 Crude and adjusted hazard ratios for different vascular events in the 5-year follow-up period

From: The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study

   Events (%) Unadjusted HR (95%CI) p Adjusted HR (95%CI) p
VTE Control group (N = 2026) 6 (0.3) 1   1  
  Cervix cancer group (N = 1013) 33 (3.3) 10.87 (4.54–25.99) <0.001 10.14 (4.19–24.54) <0.001
  1. Adjusted for age, hypertension, diabetes, coronary heart disease, hyperlipidemia, geographic region, urbanization level, and enrollee category.
  2. VTE indicates venous thromboembolism.